DARIOHEALTH CORP
DRIONASDAQ🏆 #3254 by market capUS Equity
$7.82▲ $0.74 (+9.52%)
Live1h—
24h▲ 9.5%
7d▲ 12.8%
14d▲ 4.8%
30d▲ 12.5%
1y▼ 22.2%
🏦Market Cap
$57M
Small Cap
📈Revenue Growth (YoY)
-24.4%
Declining
📊Gross Margin
56.5%
Healthy
💵FCF Margin
—
⚖️P/S Ratio
2.2x
Cheap
Otter Score
66
Fair
Trading Snapshot
- Day Range
- $7.75 – $7.97
- 52-Week Range
- $5.85 – $17.74
- Volume
- $4.41B
- Avg Volume
- $4.98B
- Shares Outstanding
- 7.3M
- Next Earnings
- Sep 18, 2026
Fundamentals Snapshot
- Annual Revenue
- $20M
- Last Q Revenue
- $5M
- P/E Ratio
- —
- P/S Ratio
- 2.2x
- EPS (TTM)
- $-10.96
- Dividend Yield
- —
Why Investors Own DRIO
- ✓High-growth profile — revenue up +25.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 78% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$20M▲ +19.5% YoY
Gross Margin (TTM)
78.1%▲ +4.3% YoY
Operating Income (TTM)
$6M▲ +19.5% YoY
Free Cash Flow (TTM)
$3M▲ +19.5% YoY
About DARIOHEALTH CORP
A company profile for DARIOHEALTH CORP isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Fair
66/100
Analyst Ratings
ⓘConsensus
Buy
10 analysts
Strong Buy3
Buy5
Hold2
Sell0
Strong Sell0
Ratings as of Aug 2026
Latest News & Updates
🚀
MarketWatch·2h ago
DARIOHEALTH CORP tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift DRIO price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
DARIOHEALTH CORP announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.